CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
18.225
1.99%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.080
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Netherlands
Commission on trade 0%

*Information provided by Capital.com

Corbion NV ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 18.595
Open* 18.495
1-Year Change* -46.73%
Day's Range* 18.155 - 18.565
52 wk Range 14.54-37.76
Average Volume (10 days) 68.84K
Average Volume (3 months) 2.46M
Market Cap 1.06B
P/E Ratio 15.89
Shares Outstanding 59.27M
Revenue 1.51B
EPS 1.12
Dividend (Yield %) 3.13725
Beta 1.04
Next Earnings Date Mar 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 18.225 -0.360 -1.94% 18.585 18.615 18.135
Feb 22, 2024 18.595 0.110 0.60% 18.485 18.815 18.295
Feb 21, 2024 18.605 -0.320 -1.69% 18.925 19.175 18.425
Feb 20, 2024 18.905 0.060 0.32% 18.845 19.075 18.595
Feb 19, 2024 18.925 0.180 0.96% 18.745 18.955 18.635
Feb 16, 2024 18.905 0.470 2.55% 18.435 19.025 18.435
Feb 15, 2024 18.315 0.230 1.27% 18.085 18.315 17.675
Feb 14, 2024 18.035 0.140 0.78% 17.895 18.165 17.505
Feb 13, 2024 18.095 -0.050 -0.28% 18.145 18.265 17.725
Feb 12, 2024 18.185 0.410 2.31% 17.775 18.255 17.695
Feb 9, 2024 17.845 -0.230 -1.27% 18.075 18.315 17.765
Feb 8, 2024 17.905 -0.200 -1.10% 18.105 18.445 17.905
Feb 7, 2024 18.125 -0.310 -1.68% 18.435 18.445 18.045
Feb 6, 2024 18.415 -0.060 -0.32% 18.475 18.725 18.155
Feb 5, 2024 18.285 0.500 2.81% 17.785 18.735 17.785
Feb 2, 2024 17.985 0.600 3.45% 17.385 18.565 17.385
Feb 1, 2024 17.195 -0.620 -3.48% 17.815 17.935 17.075
Jan 31, 2024 17.785 -0.090 -0.50% 17.875 18.775 17.745
Jan 30, 2024 18.835 -0.210 -1.10% 19.045 19.185 18.545
Jan 29, 2024 19.115 0.030 0.16% 19.085 19.285 18.505

Corbion N.V. Events

Time (UTC) Country Event
Friday, March 1, 2024

Time (UTC)

10:59

Country

NL

Event

Q4 2023 Corbion NV Earnings Release
Q4 2023 Corbion NV Earnings Release

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

10:59

Country

NL

Event

Q1 2024 Corbion NV Interim Management Statement Release
Q1 2024 Corbion NV Interim Management Statement Release

Forecast

-

Previous

-
Wednesday, May 15, 2024

Time (UTC)

10:59

Country

NL

Event

Corbion NV Annual Shareholders Meeting
Corbion NV Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1457.9 1070.8 986.5 976.4 897.2
Revenue 1457.9 1070.8 986.5 976.4 897.2
Cost of Revenue, Total 1131.5 801.8 710.6 704.1 639.1
Gross Profit 326.4 269 275.9 272.3 258.1
Total Operating Expense 1347.1 988.8 882.4 915.1 809.3
Selling/General/Admin. Expenses, Total 171.2 154.7 140.2 146.7 129.2
Research & Development 47.2 42.6 37.2 40.6 39.3
Unusual Expense (Income) -2.8 -10.3 -5.6 23.7 1.7
Operating Income 110.8 82 104.1 61.3 87.9
Interest Income (Expense), Net Non-Operating 6 6.2 -15.2 -12.7 -12.7
Other, Net -0.4 -1.7 -1.2 -3.9 -5.4
Net Income Before Taxes 116.4 86.5 87.7 44.7 69.8
Net Income After Taxes 90 78.3 73.1 25.8 54.3
Net Income Before Extra. Items 90 78.3 73.1 25.8 54.3
Net Income 90 78.3 73.1 25.8 54.3
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 90 78.3 73.1 25.8 54.3
Income Available to Common Incl. Extra. Items 90 78.3 73.1 25.8 54.3
Dilution Adjustment
Diluted Net Income 90 78.3 73.1 25.8 54.3
Diluted Weighted Average Shares 58.9918 59.4 59.5 59.4 59.3
Diluted EPS Excluding Extraordinary Items 1.52564 1.31818 1.22857 0.43434 0.91568
Dividends per Share - Common Stock Primary Issue 0.476 0.476 0.476 0.476 0.476
Diluted Normalized EPS 1.71888 1.76094 1.1563 1.58923 0.95278
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 738 770.5 687.4 555.2 515.6
Revenue 738 770.5 687.4 555.2 515.6
Cost of Revenue, Total 565.6 602.4 529.1 427.3 374.5
Gross Profit 172.4 168.1 158.3 127.9 141.1
Total Operating Expense 684.4 718.8 628.3 543.5 445.3
Selling/General/Admin. Expenses, Total 91.5 89.6 81.6 76.8 77.9
Research & Development 24.4 24.1 23.1 26.2 16.4
Unusual Expense (Income) 2.9 2.7 -5.5 13.2 -23.5
Operating Income 53.6 51.7 59.1 11.7 70.3
Interest Income (Expense), Net Non-Operating -14.3 -5.1 10.7 0 4.5
Net Income Before Taxes 39.3 46.6 69.8 11.7 74.8
Net Income After Taxes 28.1 38.2 51.8 10.8 67.5
Net Income Before Extra. Items 28.1 38.2 51.8 10.8 67.5
Net Income 28.1 38.2 51.8 10.8 67.5
Income Available to Common Excl. Extra. Items 28.1 38.2 51.8 10.8 67.5
Income Available to Common Incl. Extra. Items 28.1 38.2 51.8 10.8 67.5
Diluted Net Income 28.1 38.2 51.8 10.8 67.5
Diluted Weighted Average Shares 59.0343 59.0335 58.9501 59.8992 58.9008
Diluted EPS Excluding Extraordinary Items 0.47599 0.64709 0.87871 0.1803 1.14599
Dividends per Share - Common Stock Primary Issue 0 0.476 0 0.476 0
Diluted Normalized EPS 0.53189 0.68944 0.76336 0.47079 0.86756
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 654.3 504.5 385.1 372.5 349.6
Cash and Short Term Investments 58.2 42.2 51.6 45.7 47.1
Cash & Equivalents
Total Receivables, Net 249.2 212.4 143.8 155 144.4
Accounts Receivable - Trade, Net 210.5 163.2 123.7 124.2 119.6
Total Inventory 331.2 230 164.8 163.2 152.7
Prepaid Expenses 12 8.7 6.5 7.1 5.4
Other Current Assets, Total 3.7 11.2 18.4 1.5
Total Assets 1705.4 1341.1 1074.5 1091.1 965.8
Property/Plant/Equipment, Total - Net 729.5 532.9 406.5 433 368.9
Property/Plant/Equipment, Total - Gross 1460.7 1194.8 1027.4 1079.4 927.1
Accumulated Depreciation, Total -731.2 -661.9 -620.9 -646.4 -558.2
Goodwill, Net 83.5 77.7 70.1 80.4 61.3
Intangibles, Net 80.1 80.2 95.6 92.5 77.9
Long Term Investments 27.9 23.2 15.3 16.6 18.7
Note Receivable - Long Term 99.4 94.8 73.7 67.2 62.3
Other Long Term Assets, Total 30.7 27.8 28.2 28.9 27.1
Total Current Liabilities 592.7 321 233.9 347.7 260
Accounts Payable 148.3 128 99.4 94.3 87.8
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 322 84.6 51.4 180.1 116.3
Other Current Liabilities, Total 68.6 64.6 45.7 34.8 55.9
Total Liabilities 1079.7 787 558.5 562 445.6
Total Long Term Debt 437.2 418.6 284.4 168.9 161
Long Term Debt 376 359.1 239.5 113 159.9
Capital Lease Obligations 61.2 59.5 44.9 55.9 1.1
Deferred Income Tax 30 25.4 15.3 13.4 17
Other Liabilities, Total 19.8 22 24.9 32 7.6
Total Equity 625.7 554.1 516 529.1 520.2
Common Stock 14.8 14.8 14.8 14.8 14.8
Additional Paid-In Capital 55.2 55.2 55.2 55.2 55.2
Retained Earnings (Accumulated Deficit) 528.7 467.2 441.6 403.8 414
Other Equity, Total 27 16.9 4.4 55.3 36.2
Total Liabilities & Shareholders’ Equity 1705.4 1341.1 1074.5 1091.1 965.8
Total Common Shares Outstanding 59.0129 58.9503 58.8717 58.8196 58.7646
Total Preferred Shares Outstanding
Cash 58.2 42.2 51.6 45.7 47.1
Accrued Expenses 53.8 43.8 37.4 38.5
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 648 654.3 626.5 504.5 420.5
Cash and Short Term Investments 58.1 58.2 73.7 42.2 38.3
Cash & Equivalents 58.1 58.2 73.7 42.2 38.3
Total Receivables, Net 281.4 264.9 263.2 231.2 203.2
Accounts Receivable - Trade, Net 218.8 210.5 216 163.2 146.9
Total Inventory 308.5 331.2 289.6 230 179
Total Assets 1723.2 1705.4 1596.3 1341.1 1167.6
Property/Plant/Equipment, Total - Net 766.6 729.5 642.3 532.9 433.1
Intangibles, Net 160.5 163.6 164.3 157.9 174.9
Long Term Investments 23.4 27.9 33.4 23.2 22.1
Note Receivable - Long Term 99.8 99.4 96.6 94.8 84.2
Other Long Term Assets, Total 24.9 30.7 33.2 27.8 32.8
Total Current Liabilities 627.3 592.7 503.1 321 273.1
Accounts Payable 129.4 148.3 145.2 128 86.2
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 399.8 322 240 84.6 89.4
Other Current Liabilities, Total 98.1 122.4 117.9 108.4 97.5
Total Liabilities 1102.3 1079.7 999.5 787 606.2
Total Long Term Debt 424.7 437.2 443.7 418.6 291.3
Long Term Debt 368.7 376 379.4 359.1 247.5
Capital Lease Obligations 56 61.2 64.3 59.5 43.8
Deferred Income Tax 28.9 30 30.4 25.4 15.8
Other Liabilities, Total 21.4 19.8 22.3 22 26
Total Equity 620.9 625.7 596.8 554.1 561.4
Common Stock 14.8 14.8 14.8 14.8 14.8
Additional Paid-In Capital 55.2 55.2 55.2 55.2 55.2
Retained Earnings (Accumulated Deficit) 550.9 555.7 526.8 484.1 491.4
Total Liabilities & Shareholders’ Equity 1723.2 1705.4 1596.3 1341.1 1167.6
Total Common Shares Outstanding 59.2731 59.0129 59.0129 58.9503 58.952
Other Current Assets, Total 0 1.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 110.8 82 104.1 25.8 54.3
Cash From Operating Activities 39 22.4 109 114.4 99.5
Cash From Operating Activities 76.4 64.1 60.3 61.5 42
Non-Cash Items -3.4 -7.3 -8.7 49.9 32.6
Cash Taxes Paid 18.3 25.5 10.7 4 9.6
Cash Interest Paid 18.1 13 10.8 10 8.7
Changes in Working Capital -144.8 -116.4 -46.7 -22.8 -29.4
Cash From Investing Activities -199.1 -119.4 -76.9 -104.8 -87.6
Capital Expenditures -235.8 -148.7 -88.9 -76.2 -60.1
Other Investing Cash Flow Items, Total 36.7 29.3 12 -28.6 -27.5
Cash From Financing Activities 173.9 85.9 -23.9 -12 -4.3
Total Cash Dividends Paid -33 -33 -33 -32.9 -32.9
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net 221.8 118.9 9.1 20.9 28.6
Net Change in Cash 16 -9.4 5.9 -1.4 9
Foreign Exchange Effects 2.2 1.7 -2.3 1 1.4
Financing Cash Flow Items -14.9
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line 110.8 59.1 82 70.3
Cash From Operating Activities 39 18 22.4 15.6
Cash From Operating Activities 76.4 36.3 64.1 30.3
Non-Cash Items -3.4 -7.2 -7.3 -28.3
Cash Taxes Paid 18.3 3.8 25.5 11.5
Cash Interest Paid 18.1 7.3 13 6.2
Changes in Working Capital -144.8 -70.2 -116.4 -56.7
Cash From Investing Activities -199.1 -86.6 -119.4 -29.2
Capital Expenditures -235.8 -112.7 -148.7 -52.8
Other Investing Cash Flow Items, Total 36.7 26.1 29.3 23.6
Cash From Financing Activities 173.9 97.5 85.9 -0.2
Total Cash Dividends Paid -33 -33 -33 -33
Issuance (Retirement) of Debt, Net 221.8 145.4 118.9 32.8
Foreign Exchange Effects 2.2 2.6 1.7 0.5
Net Change in Cash 16 31.5 -9.4 -13.3
Financing Cash Flow Items -14.9 -14.9
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Goldman Sachs Advisors B.V. Investment Advisor 15.2417 9029600 0 2022-12-31 LOW
Inclusive Capital Partners LP Hedge Fund 10 5924279 0 2023-03-17 LOW
Artemis Investment Management LLP Investment Advisor/Hedge Fund 5.2756 3125410 0 2022-12-31 MED
a.s.r. vermogensbeheer Insurance Company 4.99 2956215 0 2022-12-31 LOW
Impax Asset Management Ltd. Investment Advisor 4.1482 2457492 126060 2023-09-30 LOW
Paradice Investment Management Pty. Ltd. Investment Advisor 3.07 1818754 0 2022-12-31 LOW
J O Hambro Capital Management Limited Investment Advisor/Hedge Fund 2.99 1771359 0 2022-12-31 MED
Mirova Investment Advisor 2.9812 1766153 570943 2023-05-22 LOW
Redwheel Investment Advisor/Hedge Fund 2.97 1759511 0 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.97 1759511 0 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.96 1753587 0 2022-12-31 LOW
Kabouter Management, L.L.C. Hedge Fund 2.92 1729890 0 2022-12-31 LOW
Lansdowne Partners Austria GMBH Investment Advisor 2.89 1712117 0 2022-12-31
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8812 1706887 151 2023-09-30 LOW
T. Rowe Price International Ltd Investment Advisor/Hedge Fund 2.85 1688420 0 2022-12-31 LOW
BNP Paribas Asset Management France SAS Investment Advisor/Hedge Fund 2.82 1670647 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.7747 1643813 0 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.612 955008 -6924 2023-09-30 LOW
DNCA Investments Investment Advisor 1.4691 870324 85628 2023-09-30 LOW
Van Lanschot Kempen Investment Management NV Investment Advisor/Hedge Fund 0.8461 501271 0 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Corbion Company profile

About Corbion NV

Corbion NV is a company based in the Netherlands that is active in the field of biochemical ingredients. The Company's products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. It operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The Company operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Corbion NV revenues increased 9% to EUR1.07B. Net income increased 7% to EUR78.3M. Revenues reflect Sustainable Food Solutions segment increase of 7% to EUR584.2M, Lactic Acid and Specialties segment increase of 13% to EUR312.3M, Incubator segment increase from EUR13.4M to EUR30.7M, Asia segment increase of 13% to EUR193.8M, US segment increase of 4% to EUR499.2M.

Equity composition

04/2009, Stock Dividend, 1 new share for every 21 shares held.

Industry: Specialty Chemicals (NEC)

Piet Heinkade 127
AMSTERDAM
NOORD-HOLLAND 1019 GM
NL

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

XRP/USD

0.55 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

51,106.60 Price
+0.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,035.76 Price
+0.560% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

Oil - Crude

76.56 Price
-2.240% 1D Chg, %
Long position overnight fee 0.0163%
Short position overnight fee -0.0382%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading